The anti obesity drug AOD 9604 is banned by WADA and ASADA in a blow to Essendon's defence Watson responsible for AOD 9604 use, says WADA boss Fahey FDA Peptide Reclassification 2026: What It Means for Providers AOD 9604: The Fat Loss Peptide You'll Soon Be Able to Get Again Meto blog The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York